Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading IQVIA Holdings Inc chart...

About the Company

quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com

CEO

Ari Bousbib

Exchange

NEW YORK STOCK EXCHANGE INC.

Website

https://ir.iqvia.com/

$3B

Total Revenue

68K

Employees

$46B

Market Capitalization

37.98

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $IQV News

Insiders At IQVIA Holdings Sold US$10m In Stock, Alluding To Potential Weakness

3d ago, source:

The fact that multiple IQVIA Holdings Inc. ( NYSE:IQV ) insiders offloaded a considerable amount of shares over ...

Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

8d ago, source:

In contrast to all that, many investors prefer to focus on companies like IQVIA Holdings (NYSE:IQV), which has not only ...

IQVIA (IQV) Up 5.3% Since Last Earnings Report: Can It Continue?

13d ago, source: Zacks.com on MSN

It has been about a month since the last earnings report for IQVIA Holdings (IQV). Shares have added about 5.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

IQVIA (IQV) Gains From Global IT Framework, Liquidity Low

15d ago, source: Zacks.com on MSN

IQVIA Holdings Inc. IQV has had an impressive run over the past six months. The stock has gained 21.7%, outperforming the 13.6% rally of the industry it belongs to and the 12.7% rise of the Zacks S&P ...

IQVIA Hldgs's Options Frenzy: What You Need to Know

14d ago, source:

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Antitrust & Competition Technology 2023 Year in Review

2d ago, source: JD Supra

[20] See Complaint for a Temporary Restraining Order and Preliminary Injunction, FTC v. IQVIA Holdings, Inc. and Propel Media, Inc., Case No. 1:23-cv-06188-ER (S.D.N.Y. July 18, 2022), at 3. [21] Id.

Tracking William Nygren's Harris Associates Portfolio - Q4 2023 Update

3d ago, source:

Harris Associates' 13F portfolio value increased from $51.39B to $58.34B in Q4 2023. Read more about William Nygren's ...

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

11d ago, source: The Globe and Mail

The Motley Fool has positions in and recommends Iqvia Holdings. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Paid Post: Content produced by Motley Fool. The Globe ...

Veeva Systems: A Jewel In Transition

17h ago, source:

Learn more about Veeva Systems' technological shift, projected growth, and plans to dominate the healthcare cloud software ...

Health services provider Concentra confidentially files for US IPO

on MSN ago, source:

Occupational health services provider Concentra Group, a unit of healthcare company Select Medical Holdings , said on Monday ...

Truist Financial Reaffirms Their Buy Rating on Progyny (PGNY)

14d ago, source:

Truist Financial analyst Jailendra Singh reiterated a Buy rating on Progyny (PGNY – Research Report) today. The company’s shares ...

Veeva Systems (VEEV) Fell on Revenue Guidance

1d ago, source: Yahoo Finance

In addition, check the fund’s top five holdings to know its best picks in 2023. Brown Capital Management Mid Company Fund ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...